Patent transactions in Q2 2023 soared by 345% YOY
The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023
The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023
Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges
Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities
NanoString Technologies is facing an injunction at the UPC, which has scheduled several further PI hearings in Munich and Vienna
06 September 2023
IAM speaks exclusively to Christopher Arnot about the crowded CRISPR IP landscape
25 August 2023
Having granted its first injunction ex parte, the Unified Patent Court will soon host formal hearings regarding 10x Genomics’ applications for injunctive relief
22 August 2023
IAM speaks exclusively to Jasper Clube about the CRISPR microbiome IP landscape
18 August 2023
RIS has received attention from a diverse number of players working towards creating SEP portfolios. As the technology progresses and becomes more sophisticated and with the standardisation process underway, an acceleration of patent filings in the coming years is very likely.
02 August 2023
SNIPR Biome has five patents revived but more disputes are on the horizon
18 July 2023
The plot continues to thicken in 10x Genomics’ multi-faceted spat with NanoString
13 July 2023
After winning first ever biotech AASI, 10x Genomics files first ever UP lawsuit
06 June 2023
Ethical and transparent partnerships can help resolve pressing issues all while furthering a company’s goals and interests
08 March 2023
But patentee worried further action could ‘exhaust’ it as MedTech company moves to appeal
07 February 2023
Unlock unlimited access to all IAM content